Journal Author Guidelines

SLAS journals accept manuscript submissions via the SLAS Discovery SAGE track and SLAS Technology SAGE track online manuscript submission systems.

Submissions will be returned to authors if they do not comply with the manuscript and figure guidelines that follow.

Please read these guidelines completely and carefully.

Editorial Scope

SLAS Discovery Aims and Scope

SLAS Technology Aims and Scope

Manuscript Type Descriptions and Examples

SLAS Discovery Manuscript Category Descriptions and Examples

SLAS Technology Manuscript Category Descriptions and Examples

Manuscript Guidelines and Format

All manuscripts must be written in the (American) English language and submitted as Microsoft Word documents in standard 12-point font (e.g. Times New Roman, Arial, Symbol), double-spaced with one-inch margins. Text should appear in black. Please include all elements except for figures in one Microsoft Word manuscript document. Do not use columns, section numbering, page numbering, headers or footers, boxed text, tracked changes or comments in your manuscript. Manuscripts must be prepared in accordance with ACS Style Guidelines.

Manuscripts are expected to be concise, well organized and clearly written. The manuscript must follow ACS Style Guidelines, and the format of the paper should be organized as follows:

Manuscripts should include the following sections:

  • Cover Sheet (includes title, author names and affiliations, corresponding author name and contact information for publication, and three to five keywords for indexing purposes)
  • Abstract (up to 250 words that include purpose of study or investigation, main findings, and conclusions)
  • Introduction
  • Materials and Methods
  • Results
  • Discussion
  • Acknowledgements (include funding statement)
  • References
  • Tables and Table Legends
  • Figure Legends (submit figure files separately)
  • Supplemental Files (submit supplemental files and/or videos separately)
  • Abbreviations and acronyms should be spelled out when first used. Generic names for drugs and devices are preferred over brand names. Include a manufacturer's location (city, state and country if outside U.S.) in parentheses immediately after citing the manufacturer.

  • DO NOT use more than seven (7) total figures and tables in your main document. Additional figures and tables may be added to Supplemental Files.

  • DO NOT embed tables or figures or placement instructions for tables or figures within the text of the main manuscript. Refer to figures and tables in text in accordance with ACS guidelines. Submit figures separately from the main manuscript document (see Figure Guidelines below).

  • DO NOT use tracked changes, comments, line numbering, page numbers, headers or footers in your main manuscript document. If you wish to emphasize points or passages for editors and reviewers, please do so in your cover letter. The SAGEtrack-generated PDF proof of your submission will include page numbers and line numbering. If necessary, reference those.

  • Refer to ICMJE guidelines and COPE guidelines for how to define authors and contributors. The acknowledgements section should identify collaborations, sources of research funds and other acknowledgements.

  • Recommended guidelines for assay development, validation, and data analysis are outlined in the Assay Guidance Manual prepared by Eli Lilly and Company and the National Center for Advancing Translational Sciences.

  • Authors (especially those who speak English as a second language) may wish to consider working with an author/language services company for help with editing, translation and formatting.

  • Manuscripts that require approval by an author's employer should be reviewed and cleared before they are submitted to SLAS Discovery or SLAS Technology.

Ensure citations and references comply exactly with SLAS guidelines (based on ACS guidelines).

  • Citations within the main text should be numbered (in order of occurrence) and super-scripted.
  • References should be correspondingly numbered and included as a section at the end of each paper.
  • Only the first three authors should be cited followed by "et al." Note use of periods, commas and semi-colons.
  • Article titles cited should use initial caps (i.e. of Droplet-Based Microfluidics: Enabling Impact on Drug Discovery; vs. Droplet-based microfluidics: enabling impact on drug discovery).
  • Use CASSI abbreviations
  • Names of journals, books and other periodicals should appear in italic, use initial caps, and end with a period. CASSI abbreviations should include periods. Example: J. Biomol. Screen.
  • Citations should end with year of publication (in bold); volume (in italics); and page numbers. Issue numbers are not necessary. Please use commas and periods. For example: 2014, 19, 483-496.
  • Endnote Users: Search and download SLAS Discovery and SLAS Technology style templates at
  • Helpful links: American Chemical Society and University of Wisconsin Madison.

For example:

  • Cavnar, S. P.; Salomonsson, E.; Luker, K. E.; et al. Transfer, Imaging, and Analysis Plate for Facile Handling of 384 Hanging Drop 3D Tissue Spheroids. J. Lab. Autom. 2014, 19, 208-214.
  • Dressler, O. J.; Maceiczyk, R. M.; Chang, S. I., et al. Droplet-Based Microfluidics: Enabling Impact on Drug Discovery. J. Biomol. Screen. 2014, 19, 483-496.

Figures, Tables, Mathematical Equations


Figures should be presented as simply and clearly as possible with the minimum symbology necessary to convey the information contained. Each variable in a figure should be represented in only one way — for example, either by a different symbol or by a different line pattern, but not both. To the extent possible, labels and annotations should be placed directly on the figure rather than in the caption below the figure. Recommended approaches for improving the clarity and style of figures can be found in The Visual Display of Quantitative Information by Edward Tufte. All abbreviations in figures should be spelled out in figure legends.

  • All figures, photos, and illustration should be original, high-resolution images (300 dpi).
  • Images should be at least five inches tall and no more than eight inches wide.
  • Save all figures and images as TIF or JPG files.
  • Save charts, graphs and line art as EPS files. If absolutely necessary, they can be submitted as Microsoft PowerPoint (PPTX), Word (DOC) or Excel (XLSX) files, but this is not recommended.
  • Each figure file name should include the lead author's last name and the figure number (e.g. Smith Fig 1, Smith Fig 2, Smith Fig 3, etc.).
  • For text/labels that appear within images, use Times New Roman font.

Prepare each table with a title. User Arabic numerals to number tables. Each table must be understandable independent of the text. Tables should be created in Microsoft Word and be editable. Tables should be included in the Microsoft Word main manuscript document and positioned at the end (after the references), not within the text of the manuscript.

Mathematical equations should be numbered sequentially using Arabic numbers in parentheses, for example, Eq. (1). In the text, equations should be referred to as Eq. (1), Eqs. (2)-(6). All equations should be legible so that every character is easily recognized. All symbols used should be defined in the text. If a special font (other than Symbol) is required for symbols, this should be indicated in a note to the editor.

Any text, tables, or figures reproduced from previously published work can only be reprinted with written permission from the copyright holder. Permissions statements must be submitted with the manuscript files and must include print and online publication. Acquiring permission is the sole responsibility of the author. The publication from which the material is taken must be cited in the references and any required “reprinted with permission” statements must be included as appropriate in text or legends by the author. For more detailed information about permissions, visit the RightsLink website.

When requesting permission, identify SLAS Discovery or SLAS Technology as a “Publisher, STM” (in the RightsLink dropdown menu). SLAS journals are published in partnership with SAGE Publications, and SAGE is a member of International Association of Scientific, Technical & Medical Publishers (STM), which usually allows signatory publishers and their authors to use small amounts of other signatory publishers' materials without payment of a fee. For more info, visit SAGE Rights and Permissions.

There is no charge for printed images that appear in black and white. Authors who wish to publish color images in print may do so for a fee. Color charges are $800 for the first color page and $200 for each color page thereafter. Otherwise, figures will print in black and white free of charge and they will appear in color online only. If authors choose the color option for print, an invoice will be sent later in the production process.

Supplemental Material

To complement a manuscript, authors may provide additional (supplemental) text, tables, figures, charts, graphs, data, references, movies, etc. for online publication with an article. Supplemental files should be prepared and submitted separately from the main manuscript and figure files.

  • Supplemental print materials (i.e. text, figures, tables, etc.) should be sized to fit on 8.5” x 11” pages and combined into one all-inclusive PDF file. If accepted, the file will appear online only EXACTLY AS PROVIDED, therefore please:
    • Include the title of the main manuscript that the material supplements, corresponding author name and contact info.
    • Pay attention to presentation/page layout.
    • The name of your PDF file will display online as the link to the material, so please consider this when naming and saving it. For example: Supplemental_Material_for_Droplet-Based_Microfluidics_by_Smith,_et_al. To ensure proper online publication, please use underscores in place of spaces in your file name.
  • Supplemental videos/movies may be submitted as .avi, .mpeg/mpg, or quicktime files and should not exceed 15 MBs each. The name of your video/movie file will display online as the link to the material; please consider this when naming and saving the file.

Peer Review Process

The review process is confidential and reviewers are obliged not to discuss papers or authors with anyone outside of the SLAS editorial staff. Manuscripts are typically evaluated according to these Reviewer Guidelines and initial feedback is provided to authors within four weeks after submission. Manuscripts may be accepted as written, declined as inappropriate, or as is most often the case, pending revision. Authors are then offered the opportunity to revise and resubmit their manuscript and provide explanations in response to reviewer questions or suggestions. Revisions and responses are re-reviewed by the editor-in-chief and/or peer reviewers before final publishing decisions are made. Invited reviewers are asked to decline their invitations if they have any perceived conflict of interest with the author, the author's affiliation and/or the topic of the paper.

SLAS conducts conventional single-blind reviews in which reviewer names are always concealed from the submitting author. As part of the submission process, authors are asked to provide names, company names and e-mail addresses of experts who could be called upon to review their manuscripts. Recommended reviewers (preferred reviewers) should be experts in the field who can provide objective assessments of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. For example, reviewers recommended by authors should not:

  • Have prior knowledge of an author’s submission
  • Have recently collaborated with any of the authors
  • Be from the same institution as any of the authors

Authors also are asked to share names of individuals that they do NOT want invited to review their work. SLAS editors will consider these recommendations and requests without obligation.

Author Agreement

A Contributor Form must be completed upon acceptance for publication.

To comply with the guidance for authors, publishers and research funding agencies issued by the Research Information Network (RIN), SLAS Discovery and SLAS Technology require all authors to acknowledge the sources of their funding in the Acknowledgements section of their manuscripts, or to state: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Authors whose research was funded by an NIH grant are responsible for submitting the final, accepted version of their manuscripts to PubMedCentral. Please note, however, that SLAS journals content does not become open access until 12 months following the date of final (print) publication of the manuscript. SLAS Discovery and SLAS Technology offer open access options that are compliant with major funding mandates of RCUK, NIH and Wellcome Trust. The open access fee is $3,000.

All prospective authors must recognize and disclose any conflict of interest, or potential conflict of interest, that may bias their work, or could be perceived to bias their work, and acknowledge all financial support and any other personal connections. SLAS follows the Uniform Requirements for Manuscripts of the International Committee of Medical Journal Editors.

In accordance with the Council of Science Editors, SLAS recognizes that as a general guide, the term "research misconduct" applies to any action that involves purposeful manipulation of the scientific record such that it no longer reflects observed truth, or mistreatment of research subjects. The concepts of negligence and deceit are central to the definition of research misconduct. Research misconduct generally falls into one of four areas: fabrication of data, falsification of data, plagiarism, and unethical treatment of research subjects.

If SLAS suspects misconduct by authors, reviewers, editorial staff, or other editors, it will take action. This duty extends to both published and unpublished papers. SLAS will first seek a response from those accused. If SLAS is not satisfied with the response, SLAS will ask the employers of the authors, reviewers, or editors, or some other appropriate body (perhaps a regulatory body) to investigate. In the case of its own editorial staff, SLAS will conduct the investigation itself. SLAS will make all reasonable efforts to ensure that a proper investigation is conducted. If this is not possible, or does not happen for whatever reason, SLAS will make all reasonable attempts to persist in obtaining a resolution to the problem and a correction of the record if it is needed.

Editorial Contact Information

Send any questions, suggestions, ideas or concerns regarding SLAS journals to:
Ally Jump
SLAS Publishing Manager
1301 West 22nd St., Suite 708
Oak Brook, IL 60523 USA
Tel: +1.630.256.7527, ext. 106

Open Access
SLAS Discovery and SLAS Technology offer free access to peer-reviewed scientific content one year after final (print) publication. SLAS journals also offer immediate open access options to ensure author compliance with major funding mandates of RCUK, NIH, Wellcome Trust and other agencies. The early open access fee is $3,000.

Offprints and Reprints
SAGE Publications will provide order forms and pricing information with page proofs of accepted manuscripts.